Who is affected by this change?

This affects Independence Blue Cross Radiology, Diagnostic Imaging, Oncology providers on Medicare Advantage plans.

When does this change take effect?

This change is effective Oct 1, 2025.

Back to dashboard

Medicare AdvantageCoverageMedium impact

MA09.015, Positron Emission Mammography (PEM)

Independence Blue Cross·Radiology, Diagnostic Imaging, Oncology·Medical Policy

Effective date

Oct 1, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

Medicare Advantage policy MA09.015 for Positron Emission Mammography (PEM) has been reissued effective October 1, 2025. This is a policy update that may affect coverage or billing requirements for PEM procedures under Medicare Advantage plans.

Action Required

Action needed

By October 1, 2025: Billing team should review the complete MA09.015 policy document for any changes to Positron Emission Mammography coverage, prior authorization requirements, or billing guidelines. Access the full policy at the provided URL to identify specific billing impacts and update procedures accordingly.

Related policy hubs

Independence Blue Cross policies Radiology Diagnostic Imaging Oncology